Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Iraj Sabahi Research is a clinical research organization and medical site based in California, specializing in rheumatology and autoimmune diseases. Led by Dr. Iraj Sabahi, the center conducts Phase 2 through Phase 4 clinical trials for major pharmaceutical companies, including AbbVie, Novartis, and Eli Lilly. The facility provides advanced diagnostic and therapeutic services such as IV infusion, musculoskeletal ultrasound, and regenerative medicine. Its research focus encompasses conditions like rheumatoid arthritis, osteoporosis, systemic lupus erythematosus, and psoriatic arthritis. By integrating clinical research into private practice, the company offers patients access to cutting-edge therapies and contributes to the development of new treatments in the field of rheumatology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Iraj Sabahi Research.